Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the page metadata.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical study information.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision version updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check99 days agoChange DetectedFooter updated to Revision: v3.4.2 and prior notice Revision: v3.4.1 removed; these are editorial changes that do not affect study information or site functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.